The Role of Targeted Therapies in Advanced Cholangiocarcinoma

home / investigator-perspectives / the-role-of-targeted-therapies-in-advanced-cholangiocarcinoma

A discussion on the development of targeted therapies for the management of advanced cholangiocarcinoma, with consideration of multiple ongoing trials with notable outcomes.

Metastatic Cholangiocarcinoma: Targeted Therapy and NGS

EP. 1: Metastatic Cholangiocarcinoma: Targeted Therapy and NGS

Targeted Oncology
June 25th 2020

Watch

FGFR Inhibition in Advanced CCA

EP. 2: FGFR Inhibition in Advanced CCA

Targeted Oncology
June 25th 2020

Watch

FGFR Inhibitor MOA and Adverse Events

EP. 3: FGFR Inhibitor MOA and Adverse Events

Targeted Oncology
June 25th 2020

Watch

FGFR Versus Chemotherapy: DCR/DOR Efficacy

EP. 4: FGFR Versus Chemotherapy: DCR/DOR Efficacy

Targeted Oncology
June 25th 2020

Watch

CCA Important Developments and Practical Advice

EP. 5: CCA Important Developments and Practical Advice

Targeted Oncology
June 25th 2020

Watch